pharmaphorum
MAY 24, 2021
Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on behalf of drugmaker Fresenius. . The three-country poll found that Spain is way out in front, with over half of people asked responding that digital is already playing a major role in the networking of healthcare facilities, diagnosing illnesses and telemedicine.
Outsourcing Pharma
MAY 24, 2021
The owner of the pharmacy giant has announced plans to partner with various stakeholders in an effort to effect improvements across the trial ecosystem.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
MAY 26, 2021
Some moments in life are profoundly important. Perhaps you’ve saved carefully for years to take your family on a special vacation. Or perhaps you’ve just been given a life-changing diagnosis that’s left you in a state of shock. Whether positive or negative, in a moment that important, you’re living in an altered state. Things might seem overwhelming, with the world moving too fast for you to understand what’s going on; or you may freeze, and it may feel like reality has slowed to a crawl.
Pharma Mirror
MAY 28, 2021
If you are trying to set up your own laboratory, then you should prepare for a myriad of expenses. Budgeting is a process that is required throughout the running of your lab. It keeps everything in order and ensures the continued efficiency of whatever operation or experiment you are overseeing. Without the proper financial backing, things may quickly fall apart soon after.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 26, 2021
Remember the Care.data debacle? Now, a new move by NHS England to move the records of 55 million patients into a database that will be accessible by third-party companies is under fire by privacy campaigners, who claim it could be unlawful. . The new General Practice Data for Planning and Research (GPDPR) service was unveiled earlier this month by NHS Digital, which described it as a way to “improve” the collection of patient information that would allow better planning of healthcare
Outsourcing Pharma
MAY 27, 2021
Sanofi and GSK have started the Phase 3 study for their COVID-19 vaccine candidate: eying up potential regulatory authorization in Q4, 2021.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Mission-Driven Marketing Blog
MAY 27, 2021
If the global pandemic has taught us anything, it is that so much of our nonprofit work can be done online. Over the past year, we have seen galas, 5ks, auctions, and annual fundraisers adapt to being virtual. But where does social media fit into it all?
pharmaphorum
MAY 27, 2021
Concert Pharmaceuticals has started the second of two planned phase 3 trials of its drug candidate for alopecia areata (AA), a common cause of hair loss, and says it hopes to report results in the second half of 2022. The two studies – THRIVE-AA1 and THRIVE-AA2 – are testing oral JAK1/2 inhibitor CTP-543 in adults with moderate-to-severe AA, an autoimmune disease that leads to loss of hair in patches on scalp and body.
Outsourcing Pharma
MAY 25, 2021
With the Engagement Solution Center, the patient-recruitment services specialist is aiming to improve the patient-centricity and inclusivity of studies.
Pharma Mirror
MAY 27, 2021
The second week of CPhI Discover is open amid news that both the Italian and French governments have confirmed they will allow trade shows to resume – providing formal confirmation for both CPhI Worldwide and Pharmapack Europe. The last year has seen pharma evolve its approach to meeting new partners and existing customers, with wider pools of suppliers now needed, and remote and virtual networking being used to begin conversations much earlier than in the past.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Infectious Pharmacist
MAY 25, 2021
Photo by J U N E on Pexels.com. In the midst of the firestorm over the CDC’s “guidance” (sarcastic quotes deliberately inserted) about unvaccinated persons being safe without masks in most situations, the most common question I’ve received is, “What do I do with my kids who are too young to get vaccinated?”. Today my goal is to discuss how parents can mitigate the risk of COVID-19 for their children without going insane and end with some information on the mRNA vaccines in kids.
pharmaphorum
MAY 24, 2021
Takeda has revealed long-term clinical trial results with its dengue vaccine that reinforce its safety and efficacy – and help to differentiate it from Sanofi’s challenged Dengvaxia shot. Updated results from the large-scale TIDES trial of TAK-003 show that three years after dosing it was 62% effective at warding off dengue symptoms and prevented more than 83% of hospitalisations due to the viral infection in children aged four to 16.
Outsourcing Pharma
MAY 25, 2021
Acting FDA commissioner Janet Woodcock explains how government, researchers, doctors and patients can contribute to improving the clinical research system.
Druggist
MAY 22, 2021
Gaviscon is (most likely) the most well-known brand of liquid antacid. Antacids are used to relieve symptoms of heartburn and indigestion (dyspepsia). Heartburn is a common symptom experienced during pregnancy. Today I will look into the use of Gaviscon in pregnancy by looking at the main recommendations of heartburn treatment in pregnancy. I will conclude which particular Gaviscon product is the best to use in the pregnancy. .
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
MAY 26, 2021
[link]. The post DarshanTalks: Patient Advocacy and Conflicts of Interest</br> – May 26, 2021 appeared first on Pharma Marketing Network.
pharmaphorum
MAY 27, 2021
Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first once-daily oral drug in the US to treat heavy menstrual bleeding associated with uterine fibroids. . The drug will be sold as Myfembree (relugolix) for the uterine fibroids indication, and is already available to treat prostate cancer under the Orgovyx brand name.
Outsourcing Pharma
MAY 24, 2021
According to a leader from the pharma firm, considering a patientâs needs and seeing them as a whole person is vital to successful studies and drug design.
Med Ed 101
MAY 26, 2021
I got asked a question the other day about spironolactone. Specifically, how common is gynecomastia with spironolactone? Before I answer that question, let’s take a look at some of the common clinical pearls with spironolactone. Spironolactone classified as a potassium-sparing diuretic, so from that description, we know that we have to monitor for the risk […].
Pharma Times
MAY 28, 2021
Tremfya has already been recommended for NHS use to treat eligible patient with moderate-to-severe plaque psoriasis
pharmaphorum
MAY 26, 2021
Belgium’s Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson’s one-shot COVID-19 vaccine, following the death of a woman from what appeared to be a blood clot-related condition. . The unnamed woman – who was under the age of 40 – died on 21 May after being admitted to hospital with severe thrombosis and low blood platelets, according to a statement from the Interministerial Conference on Public Health (CIM), which brings together national an
Outsourcing Pharma
MAY 27, 2021
A panel of experts at the online pharma event discussed how the pandemic created opportunities for the field but could also lead to significant challenges.
Med Ed 101
MAY 23, 2021
Melatonin is a supplement that is most often used for insomnia. I see patients take this supplement on a daily and it is also a frequent recommendation of many providers. Here are a few melatonin clinical pearls that I would recommend you pay attention to when you see a patient taking it. My first recommendation […]. The post Melatonin Clinical Pearls appeared first on Med Ed 101.
Pharma Times
MAY 24, 2021
At six and a half years 49% of patients treated with combination therapy remained alive
pharmaphorum
MAY 26, 2021
A UK tech firm with an NHS-commissioned mental health app – Hello Tomo – has been acquired by ICAS World, a company specialising in providing employee health and wellbeing services. . Hello Tomo is described as a behaviour change tool for mental health and wellbeing that aims to help users maintain healthy habits, and according to ICAS is the first of a series of acquisitions underpinning a new digital health strategy at the group.
Outsourcing Pharma
MAY 25, 2021
The medical device tech firm is poised to assist manufacturers in navigating the new European Medical Device Regulation, which goes into effect this week.
Pharma Marketing Network
MAY 26, 2021
Laura Dix, Managing Director, Life Sciences, UK breaks down ‘5 ingredients’ that are sure to make a positive impact in the interaction between pharma marketers and healthcare professionals (HCPs). COVID-19 drastically changed the playing field of HCP communication and engagement. Dix reminds us that the time has never been so important to truly differentiate when creating high-quality experiences for HCPs – experiences that HCPs deserve and will crave more of in the future when treating p
Pharma Times
MAY 24, 2021
First targeted treatment authorised in the US for NSCLC patients with EGFR exon 20 insertion mutations
pharmaphorum
MAY 25, 2021
With the ink barely dry on the FDA’s approval of Johnson & Johnson’s Rybrevant, its first bispecific antibody for cancer, the drugmaker is already showcasing others in its pipeline. . Two of its earlier-stage bispecifics – both in development for the blood cancer multiple myeloma – will feature at the American Society of Clinical Oncology (ASCO) congress, which kicks off in a few days’ time.
Outsourcing Pharma
MAY 27, 2021
Created by an industry veteran with more than 20 yearsâ experience, Protodigm aims to offer innovation and expertise to pharmaceutical industry clients.
pharmaphorum
MAY 26, 2021
Lawyers for the European Commission asked a court in Brussels today to fine AstraZeneca millions of euros for its “obvious” failure to meet the terms of its contract to supply COVID-19 vaccines to the EU. Rafael Jafferali. Counsel for the Commission – Rafael Jafferali – insisted during the hearing at the Brussels Court of First Instance that AZ had made no attempt to respect the terms of the contract, and accused the company of “diverting” around 50 million doses made wi
pharmaphorum
MAY 27, 2021
Ada Health has received another endorsement for its app to help patients diagnose conditions from symptoms, raising an impressive $90 million in funding from investors including the venture capital arm of Bayer. . Leaps by Bayer was joined by Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures in the second-round financing of the digital health player, whose app recently beat out the competition in a peer-review study published in the journal BMJ Open.
pharmaphorum
MAY 25, 2021
The UK has been a global leader in introducing cell and gene therapies that can potentially transform the lives of patients with debilitating diseases – but there are still many barriers to wider adoption. These challenges often arise because these therapies go through the same value assessment processes as less complex medicines, and the infrastructure needed to administer them to the right patients isn’t yet widely available. .
pharmaphorum
MAY 24, 2021
Shares in NGM Biopharma have plummeted after the US biotech said it would abandon development of aldafermin in non-alcoholic steatohepatitis (NASH), adding to a lengthening list of failed candidates for the fatty liver disease. . The decision was taken after a phase 2b trial of NGM’s lead drug candidate missed its primary target of showing an improvement over placebo in liver fibrosis with no worsening in stage 2 or 3 NASH at 24 weeks.
pharmaphorum
MAY 26, 2021
Vectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 billion). . The acquisition of one of the UK’s biggest biotech companies comes as Vectura is in the midst of a business restructuring that has seen it pivot away from developing its own respiratory therapies and towards an outsourcing model in which it provides contract development and manufacturing services to other biopharma compani
Expert insights. Personalized for you.
144 
Let's personalize your content